Literature DB >> 27602722

Molecular Dynamics Simulations of Amyloid β-Peptide (1-42): Tetramer Formation and Membrane Interactions.

Anne M Brown1, David R Bevan2.   

Abstract

The aggregation cascade and peptide-membrane interactions of the amyloid β-peptide (Aβ) have been implicated as toxic events in the development and progression of Alzheimer's disease. Aβ42 forms oligomers and ultimately plaques, and it has been hypothesized that these oligomeric species are the main toxic species contributing to neuronal cell death. To better understand oligomerization events and subsequent oligomer-membrane interactions of Aβ42, we performed atomistic molecular-dynamics (MD) simulations to characterize both interpeptide interactions and perturbation of model membranes by the peptides. MD simulations were utilized to first show the formation of a tetramer unit by four separate Aβ42 peptides. Aβ42 tetramers adopted an oblate ellipsoid shape and showed a significant increase in β-strand formation in the final tetramer unit relative to the monomers, indicative of on-pathway events for fibril formation. The Aβ42 tetramer unit that formed in the initial simulations was used in subsequent MD simulations in the presence of a pure POPC or cholesterol-rich raft model membrane. Tetramer-membrane simulations resulted in elongation of the tetramer in the presence of both model membranes, with tetramer-raft interactions giving rise to the rearrangement of key hydrophobic regions in the tetramer and the formation of a more rod-like structure indicative of a fibril-seeding aggregate. Membrane perturbation by the tetramer was manifested in the form of more ordered, rigid membranes, with the pure POPC being affected to a greater extent than the raft membrane. These results provide critical atomistic insight into the aggregation pathway of Aβ42 and a putative toxic mechanism in the pathogenesis of Alzheimer's disease.
Copyright © 2016 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27602722      PMCID: PMC5018154          DOI: 10.1016/j.bpj.2016.08.001

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  76 in total

1.  Molecular interactions of Alzheimer's Aβ protofilaments with lipid membranes.

Authors:  Florentina Tofoleanu; Nicolae-Viorel Buchete
Journal:  J Mol Biol       Date:  2012-01-17       Impact factor: 5.469

2.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit.

Authors:  Sander Pronk; Szilárd Páll; Roland Schulz; Per Larsson; Pär Bjelkmar; Rossen Apostolov; Michael R Shirts; Jeremy C Smith; Peter M Kasson; David van der Spoel; Berk Hess; Erik Lindahl
Journal:  Bioinformatics       Date:  2013-02-13       Impact factor: 6.937

3.  Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.

Authors:  Anne M Brown; Justin A Lemkul; Nicholas Schaum; David R Bevan
Journal:  Arch Biochem Biophys       Date:  2014-01-11       Impact factor: 4.013

Review 4.  Amyloid oligomers: formation and toxicity of Abeta oligomers.

Authors:  Masafumi Sakono; Tamotsu Zako
Journal:  FEBS J       Date:  2010-02-09       Impact factor: 5.542

5.  Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.

Authors:  Summer L Bernstein; Nicholas F Dupuis; Noel D Lazo; Thomas Wyttenbach; Margaret M Condron; Gal Bitan; David B Teplow; Joan-Emma Shea; Brandon T Ruotolo; Carol V Robinson; Michael T Bowers
Journal:  Nat Chem       Date:  2009-07       Impact factor: 24.427

Review 6.  Opinion: What is the role of protein aggregation in neurodegeneration?

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Rev Mol Cell Biol       Date:  2005-11       Impact factor: 94.444

7.  Molecular dynamics simulation of a phosphatidylglycerol membrane.

Authors:  Donald E Elmore
Journal:  FEBS Lett       Date:  2005-12-06       Impact factor: 4.124

8.  2015 Alzheimer's disease facts and figures.

Authors: 
Journal:  Alzheimers Dement       Date:  2015-03       Impact factor: 21.566

9.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

10.  Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal Membranes.

Authors:  Jo V Rushworth; Nigel M Hooper
Journal:  Int J Alzheimers Dis       Date:  2010-12-27
View more
  29 in total

1.  The membrane axis of Alzheimer's nanomedicine.

Authors:  Yuhuan Li; Huayuan Tang; Nicholas Andrikopoulos; Ibrahim Javed; Luca Cecchetto; Aparna Nandakumar; Aleksandr Kakinen; Thomas P Davis; Feng Ding; Pu Chun Ke
Journal:  Adv Nanobiomed Res       Date:  2020-11-26

2.  How accurate are your simulations? Effects of confined aqueous volume and AMBER FF99SB and CHARMM22/CMAP force field parameters on structural ensembles of intrinsically disordered proteins: Amyloid-β42 in water.

Authors:  Orkid Coskuner Weber; Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2017-10-30

3.  Characterization of Lipid-Protein Interactions and Lipid-Mediated Modulation of Membrane Protein Function through Molecular Simulation.

Authors:  Melanie P Muller; Tao Jiang; Chang Sun; Muyun Lihan; Shashank Pant; Paween Mahinthichaichan; Anda Trifan; Emad Tajkhorshid
Journal:  Chem Rev       Date:  2019-04-12       Impact factor: 60.622

4.  Atomistic-level study of the interactions between hIAPP protofibrils and membranes: Influence of pH and lipid composition.

Authors:  Zhenyu Qian; Yu Zou; Qingwen Zhang; Peijie Chen; Buyong Ma; Guanghong Wei; Ruth Nussinov
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-02-09       Impact factor: 3.747

Review 5.  Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.

Authors:  Vijayaraghavan Rangachari; Dexter N Dean; Pratip Rana; Ashwin Vaidya; Preetam Ghosh
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-03-09       Impact factor: 3.747

Review 6.  Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?

Authors:  Jacques Fantini; Henri Chahinian; Nouara Yahi
Journal:  Protein Sci       Date:  2020-07-13       Impact factor: 6.725

Review 7.  High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

Authors:  Bikash R Sahoo; Sarah J Cox; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2020-04-17       Impact factor: 6.222

8.  Coarse-grained MD simulations reveal beta-amyloid fibrils of various sizes bind to interfacial liquid-ordered and liquid-disordered regions in phase separated lipid rafts with diverse membrane-bound conformational states.

Authors:  Sara Y Cheng; Yiyi Cao; Marzieh Rouzbehani; Kwan H Cheng
Journal:  Biophys Chem       Date:  2020-03-05       Impact factor: 2.352

9.  Acetylation of Aβ42 at Lysine 16 Disrupts Amyloid Formation.

Authors:  Rashmi Adhikari; Mu Yang; Nabanita Saikia; Colina Dutta; Wafa F A Alharbi; Zhiying Shan; Ravindra Pandey; Ashutosh Tiwari
Journal:  ACS Chem Neurosci       Date:  2020-04-02       Impact factor: 4.418

10.  Binding of protofibrillar Aβ trimers to lipid bilayer surface enhances Aβ structural stability and causes membrane thinning.

Authors:  Xuewei Dong; Yunxiang Sun; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  Phys Chem Chem Phys       Date:  2017-10-18       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.